MaxCyte (NASDAQ:MXCT) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
MaxCyte reported in-line EPS of $-0.11 versus an estimate of $-0.11.
Revenue was down $3.01 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 6.43% increase in the share price the next day.
Here’s a look at MaxCyte’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.09 | -0.08 | -0.07 |
| EPS Actual | -0.05 | -0.06 | -0.08 | -0.04 |
| Revenue Estimate | 12.90M | 10.43M | 9.22M | 8.46M |
| Revenue Actual | 12.42M | 10.64M | 9.61M | 11.59M |
To track all earnings releases for MaxCyte visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
